|Articles|March 1, 2019
- Pharmaceutical Executive-03-01-2019
- Volume 39
- Issue 3
Pharmaceutical Executive, March 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Patient Advocacy: The Corporate Mandateover 7 years ago
Patient Support Programs: Cost, Benefit, and Resourcingover 7 years ago
Patients is a Virtueover 7 years ago
What Does Patient Centricity Look Like?over 7 years ago
John Crowley: Living the Missionover 7 years ago
Research Bonds Strengthenover 7 years ago
Parallel Trade a Victim of Brexit Collateral Damageover 7 years ago
Multiple Pharma Issues Top Congressional Agendaover 7 years ago
Pharm Exec Joins MJH Portfolioover 7 years ago
Cystic Fibrosis: The Importance of Patient AdvocacyAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: McKesson to Acquire Precision Medicine Group, Lundbeck & Eversana Enter AI-Powered Partnership
2
The Retailization of Medicare Advantage: What Costco’s Entry Means for Pharma
3
Why Integrated GMP Operating Models Are Reshaping Outsourced Manufacturing
4
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
5